1887

Abstract

Alterations were made in the amino terminus and the first two transmembrane-spanning regions of the latent membrane protein-1 (LMP-1) of Epstein–Barr virus. These mutant proteins were tested for their abilities to patch and to stimulate NF-κB activity. A subset of these derivatives retains the wild-type topology of LMP-1 in the plasma membrane, but has lost the ability to patch. Deletion of residues 9–20 of LMP-1, which contain potential SH3-binding motifs, abrogates patching of LMP-1. However, mutation of the prolines within these motifs, which eliminates binding of LMP-1 to SH3 domains , does not prevent patching by LMP-1. Deletion of the first two transmembrane regions of LMP-1 does prevent it patching. Some of the derivatives of LMP-1 which do not patch do stimulate NF-κB activity. Patching by LMP-1 appears to be a higher-order assemblage of protein that is compatible with the stimulation of NF-κB activity but is not necessary for this signalling.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-12-3227
1999-12-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/12/0803227.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-12-3227&mimeType=html&fmt=ahah

References

  1. Arden J. R., Segredo Z., Wang J., Lameh J., Sadee W. 1995; Phosphorylation and agonist-specific trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells. Journal of Neurochemistry 65:1636–1645
    [Google Scholar]
  2. Baichwal V. R., Sugden B. 1987; Posttranslational processing of an Epstein–Barr virus-encoded membrane protein expressed in cells transformed by Epstein–Barr virus. Journal of Virology 61:866–875
    [Google Scholar]
  3. Cicchetti P., Mayer B. J., Thiel G., Baltimore D. 1992; Identification of a protein that binds to the SH3 region of Abl and is similar to Bcr and GAP-rho. Science 257:803–806
    [Google Scholar]
  4. Clausse B., Fizazi K., Walczak V., Tetaud C., Wiels J., Tursz T., Busson P. 1997; High concentrations of the EBV latent membrane protein 1 in glycosphingolipid-rich complexes from both epithelial and lymphoid cells. Virology 228:285–293
    [Google Scholar]
  5. Feng S., Chen J. K., Yu H., Simon J. A., Schreiber S. L. 1994; Two binding orientations for peptides to the src SH3 domain: development of a general model for SH3-ligand interactions. Science 266:1241–1247
    [Google Scholar]
  6. Gires O., Zimber-Strobl U., Gonnella R., Ueffing M., Marschall G., Zeidler R., Pich D., Hammerschmidt W. 1997; Latent membrane protein 1 of Epstein–Barr virus mimics a constitutively active receptor molecule. EMBO Journal 16:6131–6140
    [Google Scholar]
  7. Grussenmeyer T., Scheidtmann K. H., Hutchinson M. A., Eckhart W., Walter G. 1985; Complexes of polyoma virus medium T antigen and cellular proteins. Proceedings of the National Academy of Sciences, USA 82:7952–7954
    [Google Scholar]
  8. Hammarskjold M., Simurda M. C. 1992; Epstein–Barr virus latent membrane protein transactivates the HIV type 1 long terminal repeat through induction of NF-κB activity. Journal of Virology 66:6496–6501
    [Google Scholar]
  9. Izumi K. M., Kaye K. M., Kieff E. D. 1994; Epstein–Barr virus recombinant molecular genetic analysis of the LMP1 amino-terminal cytoplasmic domain reveals a probable structural role, with no component essential for primary B-lymphocyte growth transformation. Journal of Virology 68:4369–4376
    [Google Scholar]
  10. Kaye K. M., Izumi K. M., Kieff E. 1993; Epstein–Barr virus latent membrane protein-1 is essential for B-lymphocyte growth transformation. Proceedings of the National Academy of Sciences, USA 90:9150–9154
    [Google Scholar]
  11. Kieser A., Kilger E., Gires O., Ueffing M., Kolch W., Hammerschmidt W. 1997; Epstein–Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade. EMBO Journal 16:6478–6485
    [Google Scholar]
  12. Kilger E., Kieser A., Baumann M., Hammerschmidt W. 1998; Epstein–Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO Journal 17:1700–1709
    [Google Scholar]
  13. Koch C. A., Anderson D., Moran M. F., Ellis C., Pawson T. 1991; SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252:668–674
    [Google Scholar]
  14. Laherty C. D., Hu H. M., Opipari A. W., Wang F., Dixit V. M. 1992; The Epstein–Barr virus LMP-1 gene product induces A20 zinc finger protein expression by activating NF-κB. Journal of Biological Chemistry 267:24157–24160
    [Google Scholar]
  15. Liebowitz D., Wang D., Kieff E. 1986; Orientation and patching of the latent infection membrane protein encoded by Epstein–Barr virus. Journal of Virology 58:233–237
    [Google Scholar]
  16. Liebowitz D., Kopan R., Fuchs E., Sample J., Kieff E. 1987; An Epstein–Barr virus transforming protein associates with vimentin in lymphocytes. Molecular and Cellular Biology 7:2299–2308
    [Google Scholar]
  17. Mann K. P., Thorley-Lawson D. 1987; Posttranslational processing of the Epstein–Barr virus-encoded p63/LMP protein. Journal of Virology 61:2100–2108
    [Google Scholar]
  18. Mann K. P., Staunton P., Thorely-Lawson D. 1985; Epstein–Barr virus-encoded protein found in the plasma membrane of transformed cells. Journal of Virology 55:710–720
    [Google Scholar]
  19. Martin J., Sugden B. 1991a; The latent membrane protein oncoprotein resembles growth factor receptors in the properties of its turnover. Cell Growth and Differentiation 2:653–660
    [Google Scholar]
  20. Martin J., Sugden B. 1991b; Transformation by the oncogenic latent membrane protein correlates with its rapid turnover, membrane localization and cytoskeletal association. Journal of Virology 65:3246–3258
    [Google Scholar]
  21. Mayer B. J., Baltimore D. 1993; Signaling through SH2 and SH3 domains. Trends in Cell Biology 3:8–13
    [Google Scholar]
  22. Miller W. E., Edwards R. H., Walling D. M., Raab-Traub N. 1994; Sequence variation in the Epstein–Barr virus latent membrane protein 1. Journal of General Virology 75:2729–2740
    [Google Scholar]
  23. Mitchell T., Sugden B. 1995; Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein–Barr virus. Journal of Virology 69:2968–2976
    [Google Scholar]
  24. Paulie S., Rosen A., Ehlin-Henriksson B., Braesch-Andersen S., Jakobson E., Koho H., Perlmann P. 1989; The human B lymphocyte and carcinoma antigen Cdw40, is a phosphoprotein involved in growth signal transduction. Journal of Immunology 142:590–595
    [Google Scholar]
  25. Ren R., Mayer B., Cicchetti P., Baltimore D. 1993; Identification of a ten-amino acid proline-rich SH3 binding site. Science 259:1157–1161
    [Google Scholar]
  26. Rothe M., Sarma V., Dixit V. M., Goeddel D. V. 1995; TRAF2-mediated activation of NF-κB by TNR receptor 2 and CD40. Science 269:1424–1427
    [Google Scholar]
  27. Sambrook J., Fritsch E. F., Maniatis T. 1989; Introduction of recombinant vectors into mammalian cells. In Molecular Cloning: A Laboratory Manual, 2nd edn. pp. 16.30–16.40 Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press;
    [Google Scholar]
  28. Sandberg M., Hammerschmidt W., Sugden B. 1997; Characterization of LMP-1’s association with TRAF1, TRAF2, and TRAF3. Journal of Virology 71:4649–4656
    [Google Scholar]
  29. Sandvej K., Gratama J. W., Munch M., Zhou X., Bolhuis R. L. H., Andresen B. S., Gregersen N., Hamilton-Dutoit S. 1997; Sequence analysis of the Epstein–Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates. Blood 90:323–330
    [Google Scholar]
  30. Speck S. H., Strominger J. L. 1989; Transcription of Epstein–Barr virus in latently infected, growth transformed lymphocytes. In Tumorigenic DNA Viruses: Advances in Viral Oncology pp. 133–150 Edited by Klein G. New York: Raven Press;
    [Google Scholar]
  31. Wilson P. T., Bourne H. R. 1995; Fatty acylation of alpha z: effects of palmitoylation and myristoylation on alpha z signaling. Journal of Biological Chemistry 270:9667–9675
    [Google Scholar]
  32. Wilson I. A., Niman H. L., Houghten R. A., Cherenson A. R., Connolly M. L., Lerner R. A. 1984; The structure of an antigenic determinant in a protein. Cell 37:767–778
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-12-3227
Loading
/content/journal/jgv/10.1099/0022-1317-80-12-3227
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error